Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
- Status
- UNKNOWN
- Phase
- PHASE2
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
- Status
- TERMINATED
- Phase
- N/A
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment
- Status
- TERMINATED
- Phase
- PHASE1
SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2